ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

Core Viewpoint - ANI Pharmaceuticals, Inc. is actively engaging with investors through upcoming presentations at two major conferences, highlighting its commitment to transparency and investor relations [1][4]. Company Overview - ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing innovative therapeutics aimed at improving patient lives [2]. - The company operates in three main segments: Rare Disease, Generics, and Established Brands, with a strong emphasis on sustainable growth [2]. Upcoming Events - ANI Pharmaceuticals will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on March 4, 2025, at 1:40 PM ET [4]. - The company will also participate in the Leerink Partners Global Healthcare Conference on March 11, 2025, at 3:40 PM ET [4].